ENDRA Life Sciences to Host Third Quarter 2020 Financial Results Conference Call and Webcast on Monday, November 16, 2020 at 4:30 p.m. ET

ANN ARBOR, MI / ACCESSWIRE / November 5, 2020 / ENDRA Life Sciences Inc. (“ENDRA”) (NASDAQ:NDRA), a pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS™), today announced that its third quarter financial results will be released on Monday, November 16, 2020 after the U.S. financial markets close. Management will host a conference call and webcast at 4:30 p.m. ET to discuss the results and provide an update on recent corporate developments.

Dial-in Number
U.S./Canada Dial-in Number: 844-369-8774
International Dial-in Number: 862-298-0844

Replay Dial-in Number: 877-481-4010
Replay International Dial-in Number: 919-882-2331
Replay Passcode: 38486

A telephone replay will be available November 16, 2020 through 4:30 p.m. ET on November 23, 2020.

A live audio webcast will be available through the Events and Presentations page of the Investors section of the company’s website at www.endrainc.com. A replay of the webcast will be available on the website for 90 days.

About ENDRA Life Sciences Inc.

ENDRA Life Sciences is the pioneer of Thermo Acoustic Enhanced UltraSound (TAEUS), a ground-breaking technology being developed to visualize tissue like CT or MRI, but at 1/50th the cost and at the point of patient care. TAEUS is designed to work in concert with the over one million ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and inflammation (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, ENDRA is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures. For more information, please visit www.endrainc.com.

Company Contact:

David Wells
Chief Financial Officer
(734) 997-0464
investors@endrainc.com
www.endrainc.com

Investor Relations Contact:

Kim Sutton Golodetz
LHA Investor Relations
(212) 838-3777
kgolodetz@lhai.com

SOURCE: ENDRA Life Sciences Inc.

View source version on accesswire.com:
https://www.accesswire.com/614644/ENDRA-Life-Sciences-to-Host-Third-Quarter-2020-Financial-Results-Conference-Call-and-Webcast-on-Monday-November-16-2020-at-430-pm-ET

Staff

Recent Posts

Avosina Healthcare Solutions Provides Notice of Data Incident

LORTON, Va., Jan. 9, 2026 /PRNewswire/ -- Avosina Healthcare Solutions ("Avosina") is notifying individuals of…

24 minutes ago

SimpleC joins Digital Medicine Society (DiMe) at CES, announces new AI-powered companion for family caregivers

Caregiver companion, named Wellby, provides 24/7 emotional support and guidance as part of SimpleC's Connected…

24 minutes ago

Prescryptive and Ilant Health Expand Employer-Direct Access to Obesity Care and Transparent GLP-1 Access at Scale

REDMOND, Wash., Jan. 9, 2026 /PRNewswire/ -- Prescryptive and Ilant Health today announced a collaboration…

25 minutes ago

Brado and Santé Ventures Partner to Transform Patient Navigation and Engagement

Investment spurs creation of Brado AI, a dedicated technology entity focused on extending provider reach…

25 minutes ago

Strategic Healthcare AI Asset “HealthcareAI.com” Positioned as Cornerstone for the Rapidly Evolving Medical Technology Sector

BILLINGS, Mont., Jan. 9, 2026 /PRNewswire/ -- As the convergence of medicine and artificial intelligence…

25 minutes ago